Federal Regulation of Probiotics: An Analysis of Existing Regulatory Framework
Federal Regulation of Probiotics: An Analysis of Existing Regulatory Framework
批准号:
8116493
负责人:
Diane E. Hoffmann
金额:
$17.63万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-04 至 2014-06-30
关键词:
AreaBenefits and RisksBiotechnologyClinicalCommunitiesComplementConsumptionDataData SourcesDatabasesDevelopmentDrug RegulationsEffectivenessEnsureEvaluationEvolutionFederal GovernmentFoodFundingFutureGenerationsGovernmentHealthHealth PolicyHumanHuman MicrobiomeHuman bodyHygieneJournalsLawsLegalLiteratureMarketingMarylandMeasuresMisinformationModelingMonitorPaperParticipantPatientsPharmaceutical PreparationsPoliciesPolicy MakerPostdoctoral FellowPreventiveProbioticsProduct LabelingPropertyPublicationsPublished CommentPublishingRecommendationRegulationRequest for ProposalsResearchResearch PersonnelReview LiteratureRiskSafetyScheduleSchoolsScienceScience PolicySeriesSourceStructureTechnologyTimeUnited StatesUniversitiesWorkWritingYogurtbaseclinical applicationconsumer productdesigndietary supplementsfood scienceinterestknowledge basemeetingsnew technologyuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Federal Regulation of Probiotics: An Analysis of the Existing Regulatory Framework and Recommendations for Alternative Frameworks. This proposal requests funding to support an evaluation of existing regulatory frameworks and their appropriateness for the regulation of new probiotic products that are available in the market or will be available in the near future. The project will include a literature review, review of existing relevant statutes and regulations, and three day-long meetings that will each bring together 15-20 invited participants from the regulatory, scientific, biotechnology, government and academic communities to discuss whether the existing regulatory framework of foods, dietary supplements, and drugs is sufficient to ensure the safety of probiotics and accuracy of health-related claims made by sellers of products with probiotic components. The focus of the proposal is the regulation of probiotic products that are or will be available to consumers for human use without a prescription and probiotic products that are or will be available to human patients in the clinical setting. Additionally, the focus of the study will be only those commercial and clinical products that promote themselves as having, or make health-related claims based on, probiotic properties. The first meeting will focus on the science of probiotics - including the current state of probiotic research, current and future clinical applications of probiotics, current and future commercial uses of probiotics, and a discussion of the benefits and risks of consuming or using probiotics. The second meeting will focus on the adequacy of the current regulatory framework for consumer products that contain probiotics components. The third meeting will focus on developing an appropriate framework for the regulation of probiotics and making regulatory policy recommendations. Following the final meeting, the Investigators will prepare a paper or series of papers, with the help of meeting participants, that will include the following topics: a) current regulation of probiotics; b) documented benefits and risks of probiotics use; c) the adequacy of the current regulatory frameworks for the regulation of probiotics; and d) if appropriate, suggested alternative regulatory models for the regulation of probiotics. PUBLIC HEALTH RELEVANCE: The field of probiotics is a new field that may or may not fit into the current regulatory framework in the United States that is in place to regulate food and drugs for human use. As with all new technologies, it is critical that an interdisciplinary discussion of possible product risks and appropriate regulation take place before uptake of the new technology makes it too burdensome or unrealistic to impose a new regulatory structure on the new technology. This project will explore the current state of probiotics research and identify current and potential uses of probiotics in consumer products and clinical applications. The Investigators will bring together experts in the area of health policy, human microbiome science, and food and drug regulation to discuss the adequacy of the current regulatory frameworks and any potential alternatives in order to provide policy makers with regulatory options designed to protect the public from misleading claims or any potential risks that might derive from the use of probiotic products.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1107/s160053681200390x
发表时间:
2012-03-01
期刊:
Acta crystallographica. Section E, Structure reports online
影响因子:
--
作者:
[Shahverdizadeh GH, Ng SW, Tiekink ER, Mirtamizdoust B]
通讯作者:
Mirtamizdoust B
Are changes to the common rule necessary to address evolving areas of research? A case study focusing on the human microbiome project.
为了应对不断发展的研究领域,是否有必要改变共同规则?
DOI:
10.1111/jlme.12055
发表时间:
2013
期刊:
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
影响因子:
--
作者:
[Hoffmann,DianeE, Fortenberry,JDennis, Ravel,Jacques]
通讯作者:
Ravel,Jacques
Probiotics: achieving a better regulatory fit.
益生菌:实现更好的监管配合。
DOI:
--
发表时间:
2014
期刊:
Food and drug law journal
影响因子:
0.2
作者:
[Hoffmann,DianeE, Fraser,ClaireM, Palumbo,Francis, Ravel,Jacques, Rowthorn,Virginia, Schwartz,Jack]
通讯作者:
Schwartz,Jack
Microbiome-Based Diagnostics: Stakeholder Perceptions and Implications for the Regulatory Framework
-
批准号:10414081
-
项目类别:
-
资助金额:$30.9万
-
财政年份:2019
-
负责人:Diane E. Hoffmann
-
依托单位:
Microbiota Transplantation: Recommendations for a Regulatory Framework
-
批准号:8951877
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2015
-
负责人:Diane E. Hoffmann
-
依托单位:
Federal Regulation of Probiotics: An Analysis of Existing Regulatory Framework
-
批准号:7923398
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2009
-
负责人:Diane E. Hoffmann
-
依托单位:
Federal Regulation of Probiotics: An Analysis of Existing Regulatory Framework
-
批准号:7743948
-
项目类别:
-
资助金额:$17.81万
-
财政年份:2009
-
负责人:Diane E. Hoffmann
-
依托单位:
海外基金